The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Muenchen, H. J., Lin, D. L., Walsh, M. A., Keller, E. T., & Pienta, K. J. (2000) · PubMed · Cited by 79
RetractedActivators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · cited 2×
“The selectivity of the transcriptional response to NF-κB will depend in part on the combinatorial response with other signalling pathway and/or transcription factors [ 64 ].”
BackgroundActivators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Insulin-promoter-factor 1 is required for pancreas development in mice
Jonsson, J., Carlsson, L., Edlund, T., & Edlund, H. (1994) · Nature · doi:10.1038/371606a0 · Cited by 1,785
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Establishment of 2-mercaptoethanol-dependent differentiated insulin- secreting cell lines
Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P. A., & Wollheim, C. B. (1992) · Endocrinology · doi:10.1210/en.130.1.167 · Cited by 1,165
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142 · cited 1×
“Similarly, acute exposure to NEFA potentiates glucose-induced insulin secretion by beta cells [12], whereas prolonged exposure to high concentrations of NEFA triggers beta cell apoptosis (lipotoxicity) [13, 14, 15 , 16, 17].”
BackgroundGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Hohmeier, H. E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M., & Newgard, C. B. (2000) · Diabetes · doi:10.2337/diabetes.49.3.424 · Cited by 917
Self-citationThorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
NF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877 · cited 2×
“Examples of anti-apoptotic proteins whose expression is increased by NF-κB are: caspase inhibitors IAP-1, IAP-2 and XIAP [49], mitochondria membrane stabilisers such as Bcl-2 [ 50 ], Bcl-xl and Bfl-1 [69], and cell-cycle regulatory proteins like cyclin D1 [70, 71].”
BackgroundGutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868 · cited 2×
“Using complementary pharmacological, biochemical and molecular biology approaches, we provide evidence that GLP-1, a gluco-incretin hormone under consideration for diabetes treatment [25, 26], prevents glucose- and palmitate-induced apoptosis in the beta cell by a mechanism involving PKB and its downstream target NF-κ…”
BackgroundHinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Poitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743
Serine/Threonine Protein Kinases and Apoptosis
Cross, T. G., Scheel-Toellner, D., Henriquez, N. V., Deacon, E., Salmon, M., & Lord, J. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4836 · Cited by 690
Lupi, R., Dotta, F., Marselli, L., Del Guerra, S., Masini, M., Santangelo, C., Patané, G., Boggi, U., Piro, S., Anello, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1437 · Cited by 595
Holz IV, G. G., Kiihtreiber, W. M., & Habener, J. F. (1993) · Nature · doi:10.1038/361362a0 · Cited by 594
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589 · cited 1×
“Finally, GLP-1 has recently been shown to delay beta cell apoptosis in Zucker diabetic rats, an animal model of diabetes [38], as well as in streptozotocin-treated mice and cytokinetreated rat islets in vitro [ 41 ].”
BackgroundSaturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic β-Cell Death
El-Assaad, W., Buteau, J., Peyot, M.-L., Nolan, C., Roduit, R., Hardy, S., Joly, E., Dbaibo, G., Rosenberg, L., & Prentki, M. (2003) · Endocrinology · doi:10.1210/en.2003-0410 · Cited by 587
Self-citationHiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., & Bensi, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6231 · Cited by 585
Stoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function
Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.1.69 · Cited by 552
FEHMANN, H.-C., GÖKE, R., & GÖKE, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 528
Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J., & Cheng, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9136 · Cited by 521
Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα
Tuttle, R. L., Gill, N. S., Pugh, W., Lee, J.-P., Koeberlein, B., Furth, E. E., Polonsky, K. S., Naji, A., & Birnbaum, M. J. (2001) · Nature Medicine · doi:10.1038/nm1001-1133 · Cited by 511
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502 · cited 2×
“Moreover, this gluco-incretin hormone increases islet mass in mouse pancreas in vivo [31, 38] and causes in vitro beta cell proliferation via transactivation of the epidermal growth factor receptor and subsequent activation of the phosphatidylinositol-3 kinase (PI-3K) and protein kinase C-ζ (PKC-ζ) signalling pathway…”
BackgroundGlucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Drucker, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0306 · Cited by 483
New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation
Chen, F., Castranova, V., & Shi, X. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61708-7 · Cited by 473
Prentki, M., & Corkey, B. E. (1996) · Diabetes · doi:10.2337/diab.45.3.273 · Cited by 469
Self-citationMalonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity
Prentki, M., Joly, E., El-Assaad, W., & Roduit, R. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s405 · Cited by 431
Self-citationMinireview: The Glucagon-Like Peptides
Drucker, D. J. (2001) · Endocrinology · doi:10.1210/en.142.2.521 · Cited by 421
Buteau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413 · cited 5×
“GLP-1 increases the DNA binding activity and expression level of the beta-cell-specific transcription factor pancreatic and duodenal homeobox gene-1 (PDX-1) [ 30 , 31], which is implicated in regulating expression of the insulin, GLUT2 and glucokinase genes, and in the regulation of beta cell differentiation [32, 33,…”
BackgroundMethodInfluentialSelf-citationTaylor, B. S., de Vera, M. E., Ganster, R. W., Wang, Q., Shapiro, R. A., Morris, S. M., Billiar, T. R., & Geller, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15148 · Cited by 413
Buteau, J., Foisy, S., Joly, E., & Prentki, M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.124 · Cited by 411
Self-citationDonath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405
Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13785 · Cited by 382
Glucose and Tolbutamide Induce Apoptosis in Pancreatic β-Cells
Efanova, I. B., Zaitsev, S. V., Zhivotovsky, B., Köhler, M., Efendić, S., Orrenius, S., & Berggren, P.-O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33501 · Cited by 364
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor
Waeber, G. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1327 · Cited by 348
Fehmann, H. C. (1992) · Endocrinology · doi:10.1210/en.130.1.159 · Cited by 337
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
Federici, M., Hribal, M., Perego, L., Ranalli, M., Caradonna, Z., Perego, C., Usellini, L., Nano, R., Bonini, P., Bertuzzi, F., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1290 · Cited by 333
Briaud, I., Harmon, J. S., Kelpe, C. L., Segu, V. B. G., & Poitout, V. (2001) · Diabetes · doi:10.2337/diabetes.50.2.315 · Cited by 316
Hui, H., Nourparvar, A., Zhao, X., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2002-220897 · Cited by 307
Gremlich, S., Bonny, C., Waeber, G., & Thorens, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30261 · Cited by 283
Buteau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252
Self-citationProtein Kinase B/Akt Prevents Fatty Acid-induced Apoptosis in Pancreatic β-Cells (INS-1)
Wrede, C. E., Dickson, L. M., Lingohr, M. K., Briaud, I., & Rhodes, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208756200 · Cited by 246
Self-citationA Dominant Negative Protein Kinase C ζ Subspecies Blocks NF-κ B Activation
Diaz-Meco, M. T., Berra, E., Municio, M., Sanz, L., Lozano, J., Dominguez, I., Diaz-Golpe, V., Lain de Lera, M. T., Alcamí, J., Payá, C. V., et al. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4770-4775.1993 · Cited by 222
Holz, G. G., Leech, C. A., Heller, R. S., Castonguay, M., & Habener, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14147 · Cited by 220
TSUBOI, T., SILVA XAVIER, G. D., HOLZ, G. G., JOUAVILLE, L. S., THOMAS, A. P., & RUTTER, G. A. (2003) · Biochemical Journal · doi:10.1042/bj20021288 · Cited by 216
Giannoukakis, N., Rudert, W. A., Trucco, M., & Robbins, P. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005943200 · Cited by 207
Warnotte, C., Gilon, P., Nenquin, M., & Henquin, J.-C. (1994) · Diabetes · doi:10.2337/diab.43.5.703 · Cited by 206
Kang, G., Chepurny, O. G., & Holz, G. G. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0375c.xd · Cited by 204
New insights into pancreatic β-cell metabolic signaling in insulin secretion
Prentki, M. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340272 · Cited by 192
Self-citationMaestre, I., Jordán, J., Calvo, S., Reig, J. A., Ceña, V., Soria, B., Prentki, M., & Roche, E. (2003) · Endocrinology · doi:10.1210/en.2001-211282 · Cited by 182
Self-citationTherapy of type 2 diabetes mellitus based on the actions of glucagon‐like peptide‐1
Holst, J. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.328 · Cited by 169
Marshak, S., Leibowitz, G., Bertuzzi, F., Socci, C., Kaiser, N., Gross, D. J., Cerasi, E., & Melloul, D. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1230 · Cited by 167
Roduit, R., Morin, J., Massé, F., Segall, L., Roche, E., Newgard, C. B., Assimacopoulos-Jeannet, F., & Prentki, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006001200 · Cited by 159
Self-citationMatsui, K., Fine, A., Zhu, B., Marshak‐Rothstein, A., & Ju, S. (1998) · PubMed · Cited by 146
Laybutt, D. R., Weir, G. C., Kaneto, H., Lebet, J., Palmiter, R. D., Sharma, A., & Bonner-Weir, S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1793 · Cited by 144
Susini, S., Roche, E., Prentki, M., & Schlegel, W. (1998) · PubMed · Cited by 133
Self-citationGlucagon-Like Peptide-I and the Control of Insulin Secretion in the Normal State and in NIDDM
Thorens, B., & Waeber, G. (1993) · Diabetes · doi:10.2337/diab.42.9.1219 · Cited by 133
A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation.
Díaz-Meco, M. T., Berra, E., Municio, M. M., et al. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4770 · Cited by 130
Sumitomo, M., Tachibana, M., Nakashima, J., Murai, M., Miyajima, A., Kimura, F., Hayakawa, M., & Nakamura, H. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61993-1 · Cited by 120
Rat Endocrine Pancreatic Development in Relation to Two Homeobox Gene Products (Pdx-1 and Nkx 6.1)
Øster, A., Jensen, J. N., Serup, P., Galante, P. E., Madsen, O. D., & Larsson, L. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600602 · Cited by 118
Alarcón, C., Wicksteed, B. L., Prentki, M., Corkey, B. E., & Rhodes, C. J. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2496 · Cited by 109
Self-citationNuclear Factor κB Protects Pancreatic β-Cells From Tumor Necrosis Factor-α-Mediated Apoptosis
Chang, I., Kim, S., Kim, J., Cho, N., Kim, Y., Kim, H. S., Lee, M., Kim, K., & Lee, M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1169 · Cited by 109
Prentki, M., & Corkey, B. E. (1996) · Diabetes · doi:10.2337/diabetes.45.3.273 · Cited by 108
Self-citationSegall, L., Davis‐Lameloise, N., Assimacopoulos‐Jeannet, F., Roche, E., Corkey, P., Thumelin, S., Corkey, B. E., & Prentki, M. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.3.e521 · Cited by 102
Self-citationAN INTEGRATED VIEW OF β-CELL DYSFUNCTION IN TYPE-II DIABETES
Poitout, D., & Robertson, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.69 · Cited by 62
Integrative Mitogenic Role of Protein Kinase B/Akt in β‐Cells
Trümper, K., Trümper, A., Trusheim, H., Arnold, R., Göke, B., & Hörsch, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06972.x · Cited by 61
Warnotte, C., Gilon, P., Nenquin, M., & Henquin, J. (1994) · Diabetes · doi:10.2337/diabetes.43.5.703 · Cited by 46
Susini, S., van Haasteren, G., Li, S., Prentki, M., & Schlegel, W. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.128 · Cited by 38
Self-citation
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes
Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491
Metadata
- Authors
- Joly, E., Prentki, M., Buteau, J., El-Assaad, W., Rhodes, C. J., & Rosenberg, L.
- Venue
- Diabetologia
- Published
- 2004-05-01
- Volume
- 47
- Issue
- 5
- Pages
- 806-815
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2001391476
- Cited by
- 337
- References
- 78
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.